Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

NeoPharm seeks orphan drug status for IL-13-PE38

Sep. 14, 2001

Provenge advances towards 2002 BLA submission

Sep. 13, 2001

AltaRex completes primary analysis of OvaRex clinical trial

Sep. 7, 2001

Positive preliminary phase II data reported for Stressgen's HspE7

Sep. 7, 2001

Major European launch announced for new CLL therapy

Sep. 7, 2001

Schering AG to amend collaboration agreement with MediGene

Sep. 6, 2001

Biomira and Merck KGaA to meet with FDA regarding Theratope vaccine

Aug. 27, 2001

Seattle Genetics initiates phase II trial with SGN-15

Aug. 27, 2001

Dendreon and Kirin broaden cancer vaccine collaboration

Aug. 24, 2001

Role of Pgp and the MDR phenotype in gemtuzumab ozogamicin resistance characterized

Aug. 24, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...